Lucida Medical

The company develops Pi, an AI-based decision support system designed to assist radiologists and clinicians in detecting and diagnosing prostate cancer using MRI scans. The software integrates with existing clinical workflows to identify clinically significant cancers, helping to rule out patients who do not require biopsies and enabling same-day diagnostic pathways. Its primary target market includes hospitals, NHS trusts, and multi-disciplinary clinical teams involved in cancer diagnostics.